Compulsory Licenses. If a compulsory license is granted to a Third Party with respect to a Therapeutic Collaboration Product in any country in the Territory with a royalty rate lower than the applicable royalty rate set forth in Section 5.2.1, then the royalty rate to be paid by the royalty-paying Party on Net Sales in that country under Section 5.2.1 shall be reduced to the rate paid by the compulsory licensee.
Appears in 2 contracts
Samples: Research Collaboration and License Agreement (Alnylam Pharmaceuticals Inc), Research Collaboration and License Agreement (Alnylam Pharmaceuticals Inc)
Compulsory Licenses. If a compulsory license is granted to a Third Party ------------------- with respect to a Therapeutic Collaboration Product in any country in the Territory with a royalty rate lower than the applicable royalty rate set forth in provided by Section 5.2.1, then the royalty rate to be paid by the royalty-paying Party Interneuron on Net Sales in that country under Section 5.2.1 shall be reduced to the rate paid by the compulsory Third Party licensee.
Appears in 1 contract
Samples: License Agreement (Interneuron Pharmaceuticals Inc)
Compulsory Licenses. If a compulsory license is granted to a Third Party third party with respect to a Therapeutic Collaboration Product in any country in the Territory with a royalty rate lower than the applicable royalty rate set forth in provided by Section 5.2.15.3.1., then the royalty rate to be * = CONFIDENTIAL TREATMENT REQUESTED: MATERIAL HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. paid by the royalty-paying Party MERCK on Net Sales in that country under Section 5.2.1 5.3.1 shall be reduced to the rate paid by the compulsory licensee.
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Neogenesis Pharmaceuticals Inc)
Compulsory Licenses. If a compulsory license is granted to a ------------------- Third Party with respect to a Therapeutic Collaboration Product in any country in the Territory with a royalty rate lower than the applicable royalty rate set forth in provided by Section 5.2.15.1.1, then the royalty rate to be paid by the royalty-paying Party PATHOGENICS on Net Sales in that country under Section 5.2.1 5.1.1 shall be reduced to the rate paid by the compulsory Third Party licensee.
Appears in 1 contract
Compulsory Licenses. If a compulsory license is granted to a Third Party with respect to a Therapeutic Collaboration Product in any country in the Territory with a royalty rate lower than the applicable royalty rate set forth in provided by Section 5.2.15.3.1, then the royalty rate to be paid by the royalty-paying Party Interneuron on Net Sales in that country under Section 5.2.1 5.3.1 shall be reduced to the rate paid by the compulsory Third Party licensee.
Appears in 1 contract
Compulsory Licenses. If a compulsory license is granted to a Third Party with respect to a Therapeutic Collaboration an Ophthalmic Product in any country in the Territory with a royalty rate lower than the applicable royalty rate set forth in this Section 5.2.18.3, then the royalty rate to be paid by the royalty-paying Party Royalty Payor on Net Sales in that country under this Section 5.2.1 8.3 shall be reduced to the rate paid by the compulsory licensee.
Appears in 1 contract
Samples: Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.)